Wednesday, Sep 30, 2020 at 7:30pm
Despite the pandemic, this has been an exciting year for the treatment of hematologic malignancies with another year of potentially blockbuster new drugs approved by the FDA or expected shortly. Just in the first week of August, a new class of drugs were approved for both Multiple Myeloma and Large Cell Lymphoma. Our physician experts will update you on these amazing new agents, as well as some that are still in the testing phase but will likely be approved in the near future. You will learn where these new drugs fit into the management of the various hematology malignancies, any clinical trials that may be open to you, and what to expect next. After the presentations, there will be an opportunity to have your questions answered – you may pre-submit questions during the registration process or ask them through the Chat function during the program.
All sessions will be moderated by Dr. Patrick Stiff of Loyola University, and will run from 7:30-9:00pm CST.
The sessions will be facilitated on Webex, an online meeting platform. Login information and instructions will be sent 5 days in advance of the session.
Aggressive Non-Hodgkin's Lymphoma
Dr. Sonali Smith, University of Chicago
CAR-T and Other Immune Therapies for Leukemia and Lymphoma
Dr. Nasheed Hossain, Loyola University
Click here For Registration
Monday, Sep 28, 2020 at 12:30pm Central Time
Tuesday, Sep 29, 2020 at 11:00am
Tuesday, Sep 29, 2020 at 7:00pm Pacific Time
Online via Zoom